Overview

In today's hypercompetitive business environment, pricing and reimbursement is the strongest determinant of profit. To have the right price for a product is one of the most important steps within the development of a new molecule. Getting to key markets quickly at the optimal price is a key to a successful launch. Therefore, having a pricing and reimbursement strategy which starts in development and evolves throughout the product lifecycle is imperative.

We help our clients strategically maximise profits via a combination of methodologies. We have a team of pricing strategy experts, focused on providing strategic guidance in pricing and reimbursement to the pharmaceutical industry.

Services

Our team has developed and perfected an analytical framework and organisational approach to managing:

• Clinical development programme guidance to maximise P&R opportunity
• Comparators for optimal pricing opportunities
• Cross indication pricing strategy assessment and recommendations
• Cross market price risk evaluation
• Environmental analysis
• International pricing
• Launch sequence modelling
• Market access
• Parallel trade minimisation modelling
• Post patent loss pricing strategy
• Price and contract intelligence
• Price monitoring & controlling
• Price setting (launch & post-launch)
• Product positioning for patient populations
• Product pricing and reimbursement strategy
• Quantitative research for price point optimisation
• Target product profile optimisation to maximise P&R opportunity